JAMES LOYD, MD
Osteopathic Medicine in Nashville, TN
License number
Tennessee MD10454
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
3601 Tvc, Nashville, TN 37232
Phone
(615) 322-3000
Personal information
See more information about JAMES LOYD at radaris.comName
Address
Phone
520 Renfroe Rd, Huntingdon, TN 38344
5 Brooks Edge Ln, Signal Mountain, TN 37377
3404 Hillmeade Ct, Nashville, TN 37221
432 Barkley Ct, Antioch, TN 37013
PO Box 465, Collierville, TN 38027
Organization information
See more information about JAMES LOYD at bizstanding.comJames Loyd MD
1301 Medical Ctr Dr, Nashville, TN 37232
Industry:
Pulmonologist, Internist
Phone:
(615) 322-2386 (Phone)
James Emory Loyd
Professional information
Method Of Diagnosing Pulmonary Hypertension
US Patent:
6642002, Nov 4, 2003
Filed:
Jul 17, 2001
Appl. No.:
09/908500
Inventors:
James E. Loyd - Nashville TN
Kirk B. Lane - Brentwood TN
Richard C. Trembath - Rutland, GB
Rajiv D. Machado - Leicester, GB
Jennifer R. Thomson - Leeds, GB
William C. Nichols - Loveland OH
Michael W. Pauciulo - Blue Ash OH
Tatiana Foroud - Indianapolis IN
Kirk B. Lane - Brentwood TN
Richard C. Trembath - Rutland, GB
Rajiv D. Machado - Leicester, GB
Jennifer R. Thomson - Leeds, GB
William C. Nichols - Loveland OH
Michael W. Pauciulo - Blue Ash OH
Tatiana Foroud - Indianapolis IN
Assignee:
Vanderbilt University - Nashville TN
Advanced Research Technology Institute - Indianapolis ID
Childrens Hospital Medical Center - Cincinnati OH
University of Leicester - Leicester
Advanced Research Technology Institute - Indianapolis ID
Childrens Hospital Medical Center - Cincinnati OH
University of Leicester - Leicester
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 235, 536 2431, 536 2433
Abstract:
This invention relates generally to a method of identifying an individual having an increased susceptibility to developing Familial Primary Pulmonary Hypertension (FPPH), as well as to a method for diagnosing an individual suffering from FPPH. The invention also relates to a method of identifying an individual having an increased susceptibility to developing (non-familial) Primary Pulmonary Hypertension (PPH), as well as to a method for diagnosing an individual suffering from PPH.
Dr. James Loyd, Nashville TN - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
VANDERBILT MEDICAL CENTER
1211 Medical Center Dr, Nashville 37232
(615) 322-5000 (Phone), (615) 343-7317 (Fax)
Vanderbilt Univ Med Ctr Plmnlgy
1301 Medical Center Dr SUITE B817, Nashville 37232
(615) 322-2386 (Phone)
1211 Medical Center Dr, Nashville 37232
(615) 322-5000 (Phone), (615) 343-7317 (Fax)
Vanderbilt Univ Med Ctr Plmnlgy
1301 Medical Center Dr SUITE B817, Nashville 37232
(615) 322-2386 (Phone)
Certifications:
Critical Care Medicine, 1997, Internal Medicine, 1978, Pulmonary Disease, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
VANDERBILT MEDICAL CENTER
1211 Medical Center Dr, Nashville 37232
Vanderbilt Univ Med Ctr Plmnlgy
1301 Medical Center Dr SUITE B817, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
1211 Medical Center Dr, Nashville 37232
Vanderbilt Univ Med Ctr Plmnlgy
1301 Medical Center Dr SUITE B817, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
West Virginia University
Graduated: 1973
Vanderbilt University
West Virginia University
Graduated: 1973
Vanderbilt University
Method For Treating Peripheral Vascular Disease By Administering Benzindene Prostaglandins By Inhalation
US Patent:
6521212, Feb 18, 2003
Filed:
Mar 15, 2000
Appl. No.:
09/525471
Inventors:
Gilles Cloutier - Chapel Hill NC
James Crow - Chapel Hill NC
Michael Wade - Chapel Hill NC
Richard E. Parker - Spring Hill TN
James E. Loyd - Nashville TN
James Crow - Chapel Hill NC
Michael Wade - Chapel Hill NC
Richard E. Parker - Spring Hill TN
James E. Loyd - Nashville TN
Assignee:
United Therapeutics Corporation - Silver Spring MD
International Classification:
A61K 912
US Classification:
424 45, 424 46, 424489, 514573, 514571
Abstract:
A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
Method Of Diagnosing Pulmonary Hypertension
US Patent:
2004002, Feb 5, 2004
Filed:
Jun 6, 2003
Appl. No.:
10/457030
Inventors:
James Loyd - Nashville TN, US
Kirk Lane - Brentwood TN, US
John Phillips - Brentwood TN, US
Richard Trembath - Oakham, GB
Rajiv Machado - Leicester, GB
Jennifer Thomson - Leeds, GB
William Nichols - Loveland OH, US
Michael Pauciulo - Blue Ash OH, US
Tatiana Foroud - Indianapolis IN, US
Kirk Lane - Brentwood TN, US
John Phillips - Brentwood TN, US
Richard Trembath - Oakham, GB
Rajiv Machado - Leicester, GB
Jennifer Thomson - Leeds, GB
William Nichols - Loveland OH, US
Michael Pauciulo - Blue Ash OH, US
Tatiana Foroud - Indianapolis IN, US
International Classification:
C12Q001/68, G01N033/53
US Classification:
435/006000, 435/007100
Abstract:
This invention relates generally to a method of identifying an individual having an increased susceptibility to developing Familial Primary Pulmonary Hypertension (FPPH), as well as to a method for diagnosing an individual suffering from FPPH. The invention also relates to a method of identifying an individual having an increased susceptibility to developing (non-familial) Primary Pulmonary Hypertension (PPH), as well as to a method for diagnosing an individual suffering from PPH.
James Emory Loyd, Nashville TN
Specialties:
Internal Medicine, Pulmonary Disease, Critical Care Medicine, Cardiovascular Disease
Work:
Vanderbilt Medical Group Specialist
3601 The Vanderbilt Clinic, Nashville, TN 37232
3601 The Vanderbilt Clinic, Nashville, TN 37232
Education:
West Virginia University (1973)
James E Loyd, Nashville TN
Specialties:
Pulmonologist
Address:
1211 22Nd Ave S, Nashville, TN 37232
Education:
West Virginia University, School of Medicine - Doctor of Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Internal Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Method For Delivering Benzindene Prostaglandins By Inhalation
US Patent:
6756033, Jun 29, 2004
Filed:
Aug 6, 2002
Appl. No.:
10/212149
Inventors:
Gilles Cloutier - Chapel Hill NC
James Crow - Chapel Hill NC
Michael Wade - Chapel Hill NC
Richard E. Parker - Spring Hill TN
James E. Loyd - Nashville TN
James Crow - Chapel Hill NC
Michael Wade - Chapel Hill NC
Richard E. Parker - Spring Hill TN
James E. Loyd - Nashville TN
Assignee:
United Therapeutics Corporation - Washington DC
International Classification:
A61K 912
US Classification:
424 45, 424 46, 424489, 514571, 514573, 560 56
Abstract:
A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
Transtracheal Oxygen Stent
US Patent:
2006015, Jul 20, 2006
Filed:
Feb 21, 2006
Appl. No.:
11/358469
Inventors:
James Loyd - Nashville TN, US
Dennis Creedon - Sandwich MA, US
Lewis Marten - Westwood MA, US
Dennis Creedon - Sandwich MA, US
Lewis Marten - Westwood MA, US
International Classification:
A62B 9/06, A61M 16/00
US Classification:
128207140, 128207150, 128207160
Abstract:
An apparatus and method for implanting a surgical apparatus including a first flange having an opening, a substantially X-shaped second flange having an opening, and a shaft having a lumen connecting the first and second flange openings. The surgical apparatus is inserted into a stoma formed in the trachea of a patient. The surgical apparatus receives and secures an oxygen supply line for patients who have difficulty breathing.
Transtracheal Oxygen Stent
US Patent:
7195016, Mar 27, 2007
Filed:
Jan 7, 2004
Appl. No.:
10/752936
Inventors:
James Loyd - Nashville TN, US
Dennis Creedon - Sandwich MA, US
Lewis H. Marten - Westwood MA, US
Dennis Creedon - Sandwich MA, US
Lewis H. Marten - Westwood MA, US
Assignee:
E. Benson Hood Laboratories - Pembroke MA
International Classification:
A61M 16/00
US Classification:
12820714, 12820026, 12820024
Abstract:
An apparatus and method for implanting a surgical apparatus including a first flange having an opening, a second flange having an opening, and a shaft having a lumen connecting the first and second flange openings. The surgical apparatus is inserted into a stoma formed in the trachea of a patient. The surgical apparatus receives and secures an oxygen supply line for patients who have difficulty breathing.
Inhalation Formulations Of Treprostinil
US Patent:
2009012, May 14, 2009
Filed:
Sep 19, 2008
Appl. No.:
12/232611
Inventors:
Gilles Cloutier - Chapel Hill NC, US
James Crow - Chapel Hill NC, US
Michael Wade - Chapel Hill NC, US
Richard E. Parker - Spring Hill TN, US
James E. Loyd - Nashville TN, US
James Crow - Chapel Hill NC, US
Michael Wade - Chapel Hill NC, US
Richard E. Parker - Spring Hill TN, US
James E. Loyd - Nashville TN, US
International Classification:
A61K 31/192
US Classification:
514569
Abstract:
The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.